Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Metas quarterly results and outlook sparked volatile trading: strong advertising growth and revenue guidance drew bullish reactions, while heavy AI infrastructure spending, negative free cash flow, a legal charge and the new non-voting share structure fueled concerns about returns and dilution. The debate centers on whether AI and ad gains can justify the spending, with some traders viewing the selloff as an overreaction.

Nokias Q3 results beat expectations, with strong AI and cloud growth and higher customer orders, but traders are frustrated that the shares have struggled despite the positive report. The debate centers on whether that demand will translate into sustained revenue and cash flow, with restructuring costs and a weak share-price response tempering bullish views.

Nebius new Citi financing facility and GTC Berlin comments on strong AI-compute demand have put its funding needs and growth plans in focus. Traders are split on whether added financing helps the company expand capacity or increases debt risk, while some point to managements account of customer prepayments and a funding model they see as less exposed than peers.

QQQ is under pressure as traders weigh Meta and Tesla results against renewed concerns about AI spending and returns: Meta raised its investment outlook while Tesla cut its capex target. The community is split between dip-buyers anticipating a rebound and bears warning of a broader tech selloff, with Iran-related oil and market risks adding to volatility.

SPY discussion centers on volatile selling tied to worries that big-tech earnings and heavy AI spending may not justify the investment, with traders also pointing to Iran tensions and elevated oil prices as added risk. The community is split between expecting further downside and buying a rebound; cyberattack concerns also appear, but are discussed speculatively.

Teslas quarterly results and outlook are driving attention: despite an adjusted earnings beat and positive cash flow, traders focused on flat revenue, weaker operating profit, reduced capital-spending guidance, and a slower Optimus ramp as shares sold off after hours. Bulls point to improving auto margins, FSD and AI potential, while bears see delayed growth and execution risks; uncertainty around a possible SpaceX merger adds to the debate.

Alphabets upcoming earnings are driving discussion as shares weaken, with traders weighing whether AI and Cloud growth can offset heavy AI spending and threats to Search advertising from competing AI products. Bears expect further downside if the outlook disappoints, while bulls are buying the dip and anticipating strong results.

Lockheed Martin is drawing attention after beating quarterly expectations, raising its annual outlook, and reporting a record backlog tied in part to strong missile demand. The reaction is mostly bullish, though some traders remain cautious about execution, margins, and F-35 funding.

The FDA accepted Biohavens resubmitted NDA for troriluzole (VYGLXIA) for spinocerebellar ataxia, setting a Q1 2027 goal date after an earlier rejection. Traders welcomed the regulatory progress, while debating the drugs commercial potential, the remaining approval uncertainty, and whether the news-driven move could give way to profit-taking.

American Airlines Q3 results and weaker outlook are driving discussion: revenue grew, but high fuel costs are weighing on margins, with the company now projecting adjusted losses for Q4 and the full year. Traders are split between focusing on resilient demand and premium revenue growth and worrying that fuel expenses and AALs debt will keep profitability under pressure.